BridgeBio Pharma, Inc. Marketable Securities (Current)
BridgeBio Pharma, Inc. (BBIO) had Marketable Securities (Current) of $7.94 million as of 2025-06-30, per its 10-Q filed 2025-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2025-08-05
- 2025-06-30: Marketable Securities, Current $7.94M.
- 2024-12-31: Marketable Securities, Current $0.00.
- 2024-06-30: Marketable Securities, Current $39.81M.
- 2024-03-31: Marketable Securities, Current $44.47M.
| Period end | Marketable Securities, Current |
|---|---|
| 2025-06-30 | $7.94M 10-Q · filed 2025-08-05 |
| 2024-12-31 | $0.00 10-Q · filed 2025-08-05 |
| 2024-06-30 | $39.81M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $44.47M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $0.00 10-Q · filed 2024-08-01 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-02 |
| 2023-06-30 | $30.87M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $34.12M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $51.58M 10-K · filed 2024-02-22 |
| 2022-09-30 | $75.08M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $218.47M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $261.90M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $393.74M 10-K · filed 2023-02-23 |
| 2021-09-30 | $419.26M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $459.24M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $447.94M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $251.01M 10-K · filed 2022-02-25 |
| 2020-09-30 | $343.71M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $300.02M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $148.13M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $182.22M 10-K · filed 2021-02-25 |
| 2019-09-30 | $122.08M 10-Q · filed 2019-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |